Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Liam Davenport

    News

    Hormonal contraceptives protective against suicide?

    Author:
    Liam Davenport
    Publish date: June 14, 2022

    The main message is the “current use of hormonal contraceptives is not associated with an increased risk of attempted suicide in our population...

    • Read More

    News

    Post-hoc analysis offers hope for novel cholesterol drug

    Author:
    Liam Davenport
    Publish date: June 10, 2022

    A second look at vupanorsen revealed its effects on VLDL and remnant cholesterol levels in TRANSLATE-TIMI 70, which had disappointing primary...

    • Read More

    News

    Genetic testing for best antidepressant accurate, cost effective

    Author:
    Liam Davenport
    Publish date: June 9, 2022

    Had psychiatrists who treated patients in the study known about their metabolizing profiles, it “might have contributed to switches in medication...

    • Read More

    News

    In utero COVID exposure tied to developmental differences in infants

    Author:
    Liam Davenport
    Publish date: June 8, 2022

    “We don’t know if these effects will result in any longer-term issues,” but longer-term observation “may help us understand this.”

    • Read More

    News

    Panitumumab beats bevacizumab in left-sided mCRC

    Author:
    Liam Davenport
    Publish date: June 6, 2022

    In the U.S., the choice between an anti-EGFR or anti-VEGF antibody for colorectal cancer has been controversial.

    • Read More

    News

    Improved survival in subset of advanced pancreatic cancer

    Author:
    Liam Davenport
    Publish date: June 4, 2022

    A new drug under study for patients with pancreatic cancer targets EGFR leading to one-year survival rates of 43.6% for patients.

    • Read More

    Article

    'New benchmark' set in phase-3 blood cancer study

    Author:
    Liam Davenport
    Publish date: June 3, 2022

    Phase 3 SHINE study of older patients with mantle cell lymphoma yields “profound” results with ibrutinib add-on.

    • Read More

    News

    LDL lowering to specific targets may offset risk from high Lp(a)

    Author:
    Liam Davenport
    Publish date: June 1, 2022

    Researchers have developed a novel app to show how the increased risk of coronary events due to elevated lipoprotein(a) levels can be countered by...

    • Read More

    News

    PPIs should be used ‘judiciously’ in patients with cirrhosis

    Author:
    Liam Davenport
    Publish date: May 11, 2022

    “Experts call for “nuanced” prescribing of proton pump inhibitors to patients with cirrhosis in study that found lower mortality only in those...

    • Read More

    News

    Misconceptions remain on gene signature use in breast cancer

    Author:
    Liam Davenport
    Publish date: May 6, 2022

    The “misconception regarding the predictive value of these tests on chemotherapy benefits suggest there is still room for training on results...

    • Read More

    News

    High antipsychotic switch rates suggest ‘suboptimal’ prescribing for first-episode psychosis

    Author:
    Liam Davenport
    Publish date: April 25, 2022

    Researchers found the most common first treatment switch, in 17.9% of patients, was from olanzapine to aripiprazole.

    • Read More

    News

    New combination med for severe mental illness tied to less weight gain

    Author:
    Liam Davenport
    Publish date: April 25, 2022

    Results of a 12-week study showed a significant difference in percent change in body weight from baseline between two treatment groups.

    • Read More

    News

    TNF inhibitors prior to surgery safe in patients with IBD: Study

    Author:
    Liam Davenport
    Publish date: April 22, 2022

    The rate of postoperative infection is no different between patients exposed to and those unexposed to tumor necrosis factor inhibitors in the 12...

    • Read More

    News

    Zanubrutinib shows worth against standard CLL drugs

    Author:
    Liam Davenport
    Publish date: April 19, 2022

    New CLL drug demonostrates its efficacy in the crowded field of CLL treatment options.

    • Read More

    News

    ‘Fragmented’ speech patterns may predict psychosis relapse

    Author:
    Liam Davenport
    Publish date: April 15, 2022

    New research suggests that “semantic speech networks can enable deeper phenotyping of formal thought disorder and psychosis.”

    • Read More

    Pages

    • « first
    • …
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery